DuFresne, Elizabeth

Preclinical safety evaluation of AAV2-sFLT01— a gene therapy for age-related macular degeneration

MacLachlan, T. K., Lukason, M., Collins, M., Munger, R., Isenberger, E., Rogers, C., Malatos, S., DuFresne, E., Morris, J., Calcedo, R., et al. (2011) · Molecular Therapy

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 166

Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization

Pechan, P., Rubin, H., Lukason, M., Ardinger, J., DuFresne, E., Hauswirth, W. W., Wadsworth, S. C., & Scaria, A. (2009) · Gene Therapy

Angiogenesis and VEGF in CancerRetinal Development and Disorders

Cited by 104